triamcinolone acetonide 5 MG/ML Topical Cream [Triderm]
triamcinolone acetonide
RxCUI: 1648999
What the CMS Formulary Data Shows for triamcinolone acetonide 5 MG/ML Topical Cream [Triderm]
Per the CMS 2026 Part D formulary file, triamcinolone acetonide 5 MG/ML Topical Cream [Triderm] (RxNorm concept RXCUI 1648999, generic name triamcinolone acetonide) appears on 185 distinct formulary files spanning 3,398 Medicare Part D plan offerings - 67.1% of enrollable Part D products, mid-range placement; shopping across contracts changes access. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 1.8.
Real-world access to triamcinolone acetonide 5 MG/ML Topical Cream [Triderm] depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 58.4% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 3,621,019 Part D beneficiaries filled triamcinolone acetonide 5 MG/ML Topical Cream [Triderm] in 2023, with total plan-and-beneficiary spending of $75,381,353 and an average per-beneficiary annual cost of $20.82. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry triamcinolone acetonide 5 MG/ML Topical Cream [Triderm] today.
Coverage Details
- Formularies covering
- 185
- Plans covering
- 3,398
- Coverage rate
- 67.1%
- Tier range
- Tier 1 – Tier 4
- Average tier
- Tier 2, Generic
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 58.4% of formularies
2023 Medicare Spending
- Beneficiaries
- 3,621,019
- Total spending
- $75,381,353
- Avg per beneficiary
- $20.82
Tier Distribution Across Plans
Standalone Drug Plans (PDP) Covering triamcinolone acetonide 5 MG/ML Topical Cream [Triderm]
5 standalone prescription drug plans include this drug.
| Plan | Insurer | Tier | PA | ST | Premium | States |
|---|---|---|---|---|---|---|
| Anthem Full Dual Advantage (PPO D-SNP) | ANTHEM HEALTH PLANS, INC. | T1 | No | No | $0 | CT |
| Anthem Dual Advantage (PPO D-SNP) | ANTHEM HEALTH PLANS, INC. | T1 | No | No | $0 | CT |
| Anthem Kidney Care (HMO-POS C-SNP) | ANTHEM HEALTH PLANS, INC. | T1 | No | No | $0 | CT |
| Anthem Full Dual Advantage Select (HMO D-SNP) | ANTHEM HEALTH PLANS, INC. | T1 | No | No | $0 | CT |
| Anthem Dual Advantage (HMO D-SNP) | ANTHEM HEALTH PLANS, INC. | T1 | No | No | $0 | CT |
Medicare Advantage Plans (MA-PD) Covering triamcinolone acetonide 5 MG/ML Topical Cream [Triderm]
95 Medicare Advantage plans with Part D drug coverage include this drug.
Frequently Asked Questions
Is triamcinolone acetonide 5 MG/ML Topical Cream [Triderm] covered by Medicare Part D?
Yes, triamcinolone acetonide 5 MG/ML Topical Cream [Triderm] is covered by 3,398 Medicare Part D plans (67.1% of all Part D formularies).
What tier is triamcinolone acetonide 5 MG/ML Topical Cream [Triderm] on Medicare Part D plans?
triamcinolone acetonide 5 MG/ML Topical Cream [Triderm] averages Tier 1.8 across Part D plans, ranging from Tier 1 to Tier 4.
Does triamcinolone acetonide 5 MG/ML Topical Cream [Triderm] require prior authorization?
0% of Part D formularies require prior authorization for triamcinolone acetonide 5 MG/ML Topical Cream [Triderm]. Step therapy: 0%. Quantity limits: 58.4%.
How much does Medicare spend on triamcinolone acetonide 5 MG/ML Topical Cream [Triderm]?
In 2023, total Medicare Part D spending on triamcinolone acetonide 5 MG/ML Topical Cream [Triderm] was $75,381,353, covering 3,621,019 beneficiaries. The average spend per beneficiary was $20.82.
Read our methodology - how this data is sourced, computed, and verified.